Noweda Pharma-Handels-Gesellschaft mit beschränkter Haftung, commonly referred to as Noweda, is a prominent player in the pharmaceutical distribution industry, headquartered in Germany. Established in 1920, the company has grown to serve a wide range of operational regions across Europe, focusing on the efficient supply of pharmaceuticals and healthcare products. Noweda is renowned for its commitment to supporting independent pharmacies, offering a comprehensive portfolio of services that includes logistics, procurement, and digital solutions tailored to the needs of its clients. The company’s unique cooperative model empowers its members, fostering a strong community within the pharmaceutical sector. With a solid market position, Noweda has achieved significant milestones, including innovative supply chain solutions and a robust network that enhances the accessibility of essential medications. Its dedication to quality and service excellence continues to set it apart in the competitive landscape of pharmaceutical distribution.
How does Noweda Pharma-Handels-Gesellschaft Mit BeschrÄNkter Haftung's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Noweda Pharma-Handels-Gesellschaft Mit BeschrÄNkter Haftung's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Noweda Pharma-Handels-Gesellschaft Mit Beschränkter Haftung currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Noweda Beteiligungs-GmbH, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Noweda Pharma-Handels-Gesellschaft Mit Beschränkter Haftung. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may rely on broader corporate family commitments. In the context of the pharmaceutical distribution industry, companies are increasingly expected to adopt robust climate action plans, including setting science-based targets for emissions reductions. However, without specific data or commitments from Noweda Pharma-Handels-Gesellschaft Mit Beschränkter Haftung, it is challenging to assess their current climate impact or future goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Noweda Pharma-Handels-Gesellschaft Mit BeschrÄNkter Haftung has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
